Drug Eluting Stents are used for the treatment of heart patients to prevent the need for more-invasive procedures, such as coronary artery bypass surgery. This reduces the need for repeated hospitalization and angioplasty procedures, thus reducing risks due to complications such as heart attack and stroke.
The Global Drug Eluting Stent market has been registering a significant growth in the recent past. This market is witnessing a consolidation of major players through strategic alliances. Moreover, the Drug Eluting Stent providers are looking forward to expand their product portfolio to provide a full range of interventional therapies to the physicians and patients.
The growth in the demand for the Drug Eluting Stent is due to its increasing acceptance as a viable treatment. Moreover, the growth is fueled by the robust economic growth and a greater adoption of social security schemes in the Asian regions. There are a large number of patients opting for these treatments so as to enhance their quality of life. Further, developed countries provide easy reimbursement options for higher-priced Drug Eluting Stent, which makes them affordable for patients. Moreover reimbursements by national medical savings schemes play a crucial role in the demand for the Drug Eluting Stents.
The report by TechNavio Insights forecasts the drug eluting stents market size of the over the period 2008-2012. Further, it discusses the segmentation of the drug eluting stents market into various geographic regions. It also identifies the key market trends, drivers and challenges and profiles some of the key vendors of this market.